TG Therapeutics Inc Sustainability Reports
TG Therapeutics, Inc. is a commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company's primary focus areas include targeted therapies for cancer and multiple sclerosis.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900X21UKABN9NJ529
FIGI: BBG001S8NH06
6 reports from 2014 to 2024